|View printer-friendly version|
|February 10, 2005 9:56 a.m.|
|Teva Announces Approval Of Amoxicillin And Clavulanate Potassium Chewable Tablets|
Jerusalem, Israel, February 10, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Amoxicillin and Clavulanate Potassium Chewable Tablets USP, 200 mg/28.5 mg and 400 mg/57 mg. Shipment of this product is expected to begin immediately.